Jinxin Fertility Group Future Growth
Future criteria checks 3/6
Jinxin Fertility Group is forecast to grow earnings and revenue by 19.6% and 11.2% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 5.1% in 3 years.
Key information
19.6%
Earnings growth rate
19.6%
EPS growth rate
Healthcare earnings growth | 16.2% |
Revenue growth rate | 11.2% |
Future return on equity | 5.1% |
Analyst coverage | Good |
Last updated | 12 Jan 2025 |
Recent future growth updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Jinxin Fertility Group (HKG:1951)
Jan 06Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 09Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Nov 13Jinxin Fertility Group Limited's (HKG:1951) 30% Jump Shows Its Popularity With Investors
Sep 27Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Sep 02Jinxin Fertility Group (HKG:1951) Will Want To Turn Around Its Return Trends
May 30After Leaping 25% Jinxin Fertility Group Limited (HKG:1951) Shares Are Not Flying Under The Radar
May 13These 4 Measures Indicate That Jinxin Fertility Group (HKG:1951) Is Using Debt Reasonably Well
May 05What Is Jinxin Fertility Group Limited's (HKG:1951) Share Price Doing?
Mar 12Capital Allocation Trends At Jinxin Fertility Group (HKG:1951) Aren't Ideal
Feb 14With Jinxin Fertility Group Limited (HKG:1951) It Looks Like You'll Get What You Pay For
Dec 25What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Dec 08Jinxin Fertility Group (HKG:1951) Is Reinvesting At Lower Rates Of Return
Oct 22Jinxin Fertility Group (HKG:1951) Takes On Some Risk With Its Use Of Debt
Sep 20What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Sep 04Are Investors Undervaluing Jinxin Fertility Group Limited (HKG:1951) By 43%?
May 30Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Apr 20An Intrinsic Calculation For Jinxin Fertility Group Limited (HKG:1951) Suggests It's 34% Undervalued
Feb 27Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jan 09Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 11Some Investors May Be Worried About Jinxin Fertility Group's (HKG:1951) Returns On Capital
Nov 28Jinxin Fertility Group Limited (HKG:1951) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 03Is Jinxin Fertility Group Limited (HKG:1951) Potentially Undervalued?
Oct 04Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Sep 07Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jun 06Jinxin Fertility Group (HKG:1951) Has A Rock Solid Balance Sheet
Apr 05What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Feb 25The Returns On Capital At Jinxin Fertility Group (HKG:1951) Don't Inspire Confidence
Jan 21Why Jinxin Fertility Group Limited (HKG:1951) Could Be Worth Watching
Nov 15Jinxin Fertility Group (HKG:1951) Seems To Use Debt Quite Sensibly
Oct 11Returns On Capital At Jinxin Fertility Group (HKG:1951) Paint A Concerning Picture
Sep 28Jinxin Fertility Group Limited's (HKG:1951) Intrinsic Value Is Potentially 44% Above Its Share Price
Sep 15Should You Think About Buying Jinxin Fertility Group Limited (HKG:1951) Now?
Jul 20Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Jun 29Are Jinxin Fertility Group Limited (HKG:1951) Investors Paying Above The Intrinsic Value?
Jun 09What Type Of Shareholders Make Up Jinxin Fertility Group Limited's (HKG:1951) Share Registry?
Mar 15Are Jinxin Fertility Group Limited (HKG:1951) Investors Paying Above The Intrinsic Value?
Feb 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 4,285 | 612 | 855 | N/A | 1 |
12/31/2026 | 3,862 | 564 | 611 | 992 | 11 |
12/31/2025 | 3,481 | 479 | 628 | 907 | 14 |
12/31/2024 | 3,046 | 408 | 482 | 828 | 11 |
6/30/2024 | 2,899 | 311 | 560 | 731 | N/A |
3/31/2024 | 2,844 | 328 | 536 | 708 | N/A |
12/31/2023 | 2,789 | 345 | 511 | 684 | N/A |
9/30/2023 | 2,675 | 250 | 495 | 645 | N/A |
6/30/2023 | 2,560 | 155 | 480 | 606 | N/A |
3/31/2023 | 2,462 | 138 | 31 | 574 | N/A |
12/31/2022 | 2,364 | 121 | -418 | 542 | N/A |
9/30/2022 | 2,241 | 248 | -479 | 492 | N/A |
6/30/2022 | 2,118 | 374 | -541 | 442 | N/A |
3/31/2022 | 1,978 | 357 | -139 | 393 | N/A |
12/31/2021 | 1,839 | 340 | 264 | 343 | N/A |
9/30/2021 | 1,756 | 316 | 190 | 374 | N/A |
6/30/2021 | 1,674 | 291 | 117 | 405 | N/A |
3/31/2021 | 1,550 | 271 | 51 | 356 | N/A |
12/31/2020 | 1,426 | 252 | -15 | 308 | N/A |
9/30/2020 | 1,448 | 304 | -21 | 295 | N/A |
6/30/2020 | 1,469 | 356 | -27 | 281 | N/A |
3/31/2020 | 1,559 | 383 | 74 | 367 | N/A |
12/31/2019 | 1,648 | 410 | 175 | 453 | N/A |
9/30/2019 | 1,475 | 339 | 302 | 457 | N/A |
6/30/2019 | 1,301 | 269 | 428 | 461 | N/A |
3/31/2019 | 1,112 | 218 | 382 | 409 | N/A |
12/31/2018 | 922 | 167 | 335 | 356 | N/A |
12/31/2017 | 663 | 99 | N/A | 48 | N/A |
12/31/2016 | 346 | 88 | N/A | 109 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1951's forecast earnings growth (19.6% per year) is above the savings rate (2.3%).
Earnings vs Market: 1951's earnings (19.6% per year) are forecast to grow faster than the Hong Kong market (11.3% per year).
High Growth Earnings: 1951's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1951's revenue (11.2% per year) is forecast to grow faster than the Hong Kong market (7.6% per year).
High Growth Revenue: 1951's revenue (11.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1951's Return on Equity is forecast to be low in 3 years time (5.1%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/21 05:44 |
End of Day Share Price | 2025/01/21 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jinxin Fertility Group Limited is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sharon Shi | BOCI Research Ltd. |
Ethan Cui | BofA Global Research |
Qianyi Li | China International Capital Corporation Limited |